Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension.
Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension.
Omidenepag was approved for medical use in Japan in 2018, and in the United States in September 2022.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).